FDA issues psychedelic therapy guidance as Clearmind notes federal push
Go back to FDA issues psychedelic therapy guidance as Clearmind notes federal push| (NASDAQ: CMND) | Delayed: 1.94 -0.05 (2.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.99 | 52 Week High | $ | |||
| Open | $1.90 | 52 Week Low | $ | |||
| Day High | $1.99 | P/E | N/A | |||
| Day Low | $1.81 | EPS | $ | |||
| Volume | 192,794 | |||||
